Supply chain distribution is used to balance supply and demand. Learn more about the importance of having a distribution plan ...

This month, I'm excited to share the results of Fictiv’s 10th Annual State of Manufacturing & Supply Chain Report. Every year, we survey hundreds of supply chain and manufacturing leaders across ...

Since 2020, supply chains have been in a period of transformation. Companies first sought to maintain continuity in the face of massive disruption and then pivoted to improve resiliency and manage ...

The tech sector often produces rapid innovation and growth in waves. A few years ago, the COVID-19 pandemic brought unprecedented unpredictability, leading to an initial stall, followed by a massive ...

SKU segmentation aligns strategy with execution. Dividing products into strategic segments allows companies to match supply chain policies like inventory levels, service targets, ...

As 2025 comes to an end, where do we stand with AI in the supply chain? What is real? What is hype? Machine learning has been a part of advanced demand forecasting for over 20 years. But these ...

This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. Supply chain finance (SCF) – also known as reverse factoring – ...

In the past five months, uncertainty around tariffs has upended the supply-chain landscape. What should manufacturers be doing now to shore up their supply base when policy can change with the tides?

Supply chains leaders are facing unprecedented pressures as they navigate challenges such as policy changes, rising costs and tariff implications. This is causing health systems to rethink traditional ...

As the owner of a growing business, you might consider ways to sustainably finance your company. Two popular options are supply chain finance programs and invoice factoring. Supply chain finance ...

Hospital supply chain leaders say the playbook that worked just a few years ago no longer holds. Global economic instability, fragile supplier networks, pricing pressures and uneven clinical ...